stella
beta
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants — Stella
Recruiting
Back to Healthy Volunteers trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(3 sites)
United States
Anaheim Clinical Trials, Anaheim, California
ICON - Lenexa, Lenexa, Kansas
ICON Development Solutions, San Antonio, Texas
View full record on ClinicalTrials.gov